DPDario Petrone

Dario Petrone

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dario Petrone has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sequential Arch-Tear Eligibility for Uncovered Aortic Arch Stent in Acute DeBakey Type I Aortic Dissection

    by Dario Petrone, Bruno Chiarello, Giulia Bessi, Alan Ciardo, Beatrice Bacchi, Francesco Cabrucci, Aleksander Dokollari, Antonio Rosciano, Edvin Prifti, Massimo Bonacchi

    Background: Because an uncovered arch scaffold does not provide a covered seal across an unresected arch tear, we evaluated a source-adjudicated sequential eligibility framework separating study-defined stop gates from residual-risk modifiers. Methods: We retrospectively analyzed 266 patients with acute DeBakey type I dissection treated by hemiarch repair alone (No. = 160) or hemiarch plus AMDS (No. = 106). Blinded preoperative CT-scan re-review validated Gate 1 (visible arch tear), and operative-report review confirmed Gate 2 (tear directly observed at open inspection). Supra-aortic false-lumen communication was assessed only after both gates were negative. Results: Sixty-nine patients (25.9%) passed both study-defined gates (AMDS = 32; hemiarch = 37). Twelve-month CT-scan was available in 45/69 (65.2%; AMDS 24/32, hemiarch 21/37). Among imaged patients, complete zone 2–3 false-lumen exclusion occurred in 20/24 (83.3%) after AMDS and 0/21 after hemiarch (risk difference +83.3 percentage points, 95% CI +58.7 to +93.3; p < 0.001). DANE occurred in 4/32 (12.5%) and 16/37 (43.2%), respectively (p = 0.007). Under the adverse opposing missingness scenario, the exclusion risk difference narrowed to +19.3 percentage points (95% CI −4.2 to +39.9; p = 0.148). Conclusions: These findings are hypothesis-generating and apply to a selected post hoc subgroup; treatment comparisons are non-causal. Prospective external validation of the study-defined hierarchy remains required.

  • Open Access

    Clinical and Radiological Outcomes of Acute Type A Aortic Dissection Repair with the Ascyrus Medical Dissection Stent

    by Francesco Cabrucci, Beatrice Bacchi, Dario Petrone, Massimo Baudo, Dimitrios E. Magouliotis, Yoshiyuki Yamashita, Serge Sicouri, Massimo Bonacchi, Sandro Gelsomino, Basel Ramlawi

    Objective: This study aimed to evaluate clinical and radiological outcomes of Ascyrus Medical Dissection Stent (AMDS®, Artivion Inc.) for acute type A aortic dissection (ATAAD). Methods: Between January 2021 and January 2025, all consecutive patients undergoing emergent surgery for ATAAD and hybrid aortic arch repair using the AMDS from two centers were retrospectively analyzed. Demographic, intraoperative, and postoperative data were collected. Patients were stratified based on 30-day or in-hospital mortality. Survival analysis was performed for patients who survived hospital discharge. Radiological evaluation focused on the presence of distal anastomotic new entries (DANEs), false lumen thrombosis, and aortic remodeling on follow-up computed tomography angiography. A total of 46 patients (12 female, mean age 66.1 ± 13.8 years) were included in the study. Results: The 30-day or in-hospital mortality rate was 21.7% (10 patients). There were no significant differences in demographic variables between survivors and non-survivors. All patients underwent hemiarch replacement with AMDS stent placement, with 54.3% also requiring aortic root replacement. Median cross-clamp time, hypothermic circulatory arrest (HCA) time, and time of antegrade selective cerebral perfusion did not differ significantly between the two groups. However, significant differences were observed in median cardiopulmonary bypass (CPB) time (151 vs. 274 min, p = 0.02) and HCA temperature (27 °C vs. 25 °C, p = 0.021). Postoperatively, the non-survivor group showed a significantly higher incidence of dialysis requirement (7.7% vs. 60.0%, p = 0.02), use of mechanical circulatory support (3.9% vs. 44.4%, p = 0.01), and re-exploration for bleeding (15.4% vs. 66.7%, p = 0.023). Conclusions: The AMDS® is an effective adjunct in hemiarch replacement for ATAAD. Moderate hypothermia and optimized perfusion were linked to better early survival, while the device reliably promoted true-lumen expansion with few DANEs. Its rapid deployment may further facilitate the use of moderate hypothermia by balancing procedural efficiency with systemic protection.


  • Open Access

    Prognostic Role of the Modified Frailty Index in Octogenarians Undergoing Minimally Invasive Aortic Valve Replacement

    by Beatrice Bacchi, Francesco Cabrucci, Dario Petrone, Giulia Bessi, Tommaso Pacini, Aleksander Dokollari, Massimo Bonacchi

    Objectives: Frailty is increasingly recognized as a key determinant of surgical risk in elderly patients undergoing aortic valve replacement (AVR). This study aimed to evaluate the prognostic value of the modified Frailty Index (mFI) in a homogeneous cohort of octogenarians undergoing minimally invasive surgical AVR, to enhance risk stratification and guide surgical decision-making. Methods: We retrospectively analyzed 67 patients aged ≥ 80 years (mean 84.1 ± 3.2) who underwent isolated minimally invasive AVR. The mFI was calculated preoperatively using standardized clinical variables. Primary outcomes included 30-day mortality and perioperative complications; long-term survival was also assessed. Receiver operating characteristic (ROC) curves identified optimal mFI cut-offs. Kaplan-Meier and Cox regression analyses were used to evaluate survival and predictors of mortality. Results: The mFI demonstrated a strong prognostic accuracy. An mFI > 0.455 predicted 30-day mortality with 81.8% sensitivity and 88.4% specificity (AUC = 0.888, p < 0.001), while an mFI > 0.273 predicted perioperative complications (AUC = 0.818, p < 0.001). During a median follow-up of 51.8 ± 36.4 months, 24 patients (45.3%) died. One-year survival was 83.7%. The mFI > 0.455 was the strongest independent predictor of early mortality (HR 6.34, p = 0.001); mFI > 0.273, HFpEF with NT-proBNP > 1000 pg/mL, and chronic kidney disease were predictors of long-term mortality. Conclusions: The mFI is a simple, reproducible tool that reliably predicts early and late outcomes in very elderly patients undergoing minimally invasive AVR. Integrating frailty into preoperative evaluation may improve patient selection by prioritizing physiological over chronological age.


  • Open Access

    Not All SAVR Are Created Equal: All the Approaches Available for Surgical Aortic Valve Replacement

    by Francesco Cabrucci, Serge Sicouri, Massimo Baudo, Dimitrios E. Magouliotis, Yoshiyuki Yamashita, Beatrice Bacchi, Dario Petrone, Beman Wasef, Aleksander Dokollari, Massimo Bonacchi, et al.

    Surgical Aortic Valve Replacement (SAVR) is still one of the pillars of cardiac surgery practice, and its role is evolving into a more complex operation. The competition with structural valve therapies and the urgent demand for less invasive solutions have unleashed surgeons’ creativity in adapting to these new challenges. All the possible ways to surgically replace the aortic valve are analyzed in this review. Surgical techniques, advantages and disadvantages, and key differences are listed, helping surgeons navigate the available options. Sternotomy SAVR is the benchmark, but that is becoming obsolete and, in some cases, no longer performed for teaching purposes. Mini sternotomy is the easiest way to achieve minimal invasiveness in all anatomic situations, while right anterior thoracotomy is an elegant solution mastered by fewer surgeons. Endoscopic and robotic-assisted techniques are shaping the future of SAVR, yet they still lack wide adoption. The choice of approach is mainly dictated by the anatomic features of the patient and the surgeon’s skills. A flow diagram to overcome the learning curve and advance toward more complex surgery is provided here. Mastering as many techniques as possible is paramount when offering a patient-tailored approach and performing a safe and less invasive operation.